Tanimoto Sarina
SEC insider (Form 3/4/5 filer). CIK 0001951291. CHIEF MEDICAL OFFICER at ARS Pharmaceuticals, Inc. (SPRY). 28 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in SAN DIEGO, CA.
Companies Tanimoto Sarina has filed insider reports for
- ARS Pharmaceuticals, Inc. (SPRY): Officer, 10% Owner, CHIEF MEDICAL OFFICER
Tanimoto Sarina
CIK: 0001951291
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ARS Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (28 total)
- Jan 2, 2026SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
240K shares- - Jan 2, 2026SPRY
ARS Pharmaceuticals, Inc.
AwardIndirectStock Option (right to buy)
875K shares- - Aug 20, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleIndirect37.7K shares at avg. $14.09$531K - Aug 19, 2025SPRY
ARS Pharmaceuticals, Inc.
SaleIndirect12.3K shares at avg. $14.03$173K - Jan 2, 2025SPRY
ARS Pharmaceuticals, Inc.
AwardDirectStock option (right to buy)
261.9K shares- - Jan 2, 2025SPRY
ARS Pharmaceuticals, Inc.
AwardIndirectStock Option (right to buy)
767.6K shares- - Dec 17, 2024SPRY
ARS Pharmaceuticals, Inc.
SaleIndirect50K shares at avg. $11.67$584K - Dec 17, 2024SPRY
ARS Pharmaceuticals, Inc.
SaleIndirect50K shares at avg. $11.67$584K - Dec 10, 2024SPRY
ARS Pharmaceuticals, Inc.
SaleIndirect50K shares at avg. $13.16$658K - Dec 10, 2024SPRY
ARS Pharmaceuticals, Inc.
SaleIndirect50K shares at avg. $13.17$658K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 | SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 240,000 | - | - | Direct |
| Jan 2, 2026 | SPRY ARS Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 875,000 | - | - | Indirect |
| Aug 20, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 37,656 | $14.09 | $530,626 | Indirect |
| Aug 19, 2025 | SPRY ARS Pharmaceuticals, Inc. | Sale | 12,344 | $14.03 | $173,130 | Indirect |
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award Stock option (right to buy) | 261,900 | - | - | Direct |
| Jan 2, 2025 | SPRY ARS Pharmaceuticals, Inc. | Award Stock Option (right to buy) | 767,600 | - | - | Indirect |
| Dec 17, 2024 | SPRY ARS Pharmaceuticals, Inc. | Sale | 50,000 | $11.67 | $583,575 | Indirect |
| Dec 17, 2024 | SPRY ARS Pharmaceuticals, Inc. | Sale | 50,000 | $11.67 | $583,525 | Indirect |
| Dec 10, 2024 | SPRY ARS Pharmaceuticals, Inc. | Sale | 50,000 | $13.16 | $658,155 | Indirect |
| Dec 10, 2024 | SPRY ARS Pharmaceuticals, Inc. | Sale | 50,000 | $13.17 | $658,265 | Indirect |
1-10 of 28 transactions